We are monitoring the impact of COVID-19 on Asia Pacific RIA Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Radioimmunoassay Market Research Report – Segmented By Type, End User, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3558
Pages: 145

APAC RIA Market Size (2022 to 2027)

The size of the Asia Pacific Radioimmunoassay Market was calculated at USD 74.17 million in 2022. It is further estimated to be growing at a CAGR of 4.2% and values USD 91.11 million by 2027.

Applications of radioimmunoassay can be used for infectious diseases, toxicology, neonatal analysis oncology, endocrinology, cardiology, hematology and blood tests, bone and mineral disorders, and autoimmune disorders. This increasing prevalence of diseases, which require technologically advanced products for the diagnosis, is responsible for driving the growth of the APAC radioimmunoassay market during the forecast period.

In the biotechnology and pharmaceutical industry, radioimmunoassay is used for drug screening. However, the need for personalized diagnostics and treatment will drive the market in the years to come. For example, the World Health Organization (WHO) report indications that around 36% of nutritional deficiencies, 38% of perinatal conditions, 31% of respiratory disease, 34% of maternal conditions infections, and 28% of the global burden of infectious diseases and parasitic diseases are widespread in this region. APAC regions have seen a rapid increase in cardiovascular diseases (CVD) in the past several years. One in six Australians suffers from CVD, which represents more than 4 million Australians. This indicates that approximately 16.7% of the total Australian population is living with CVD. Among the Korean adult patients, the prevalence of clinically diagnosed CVD per 1000 people was reported to be 101.11 in 2015 and 103 in 2016. In the Japanese population, the death rate from CVD among age group above 80 fell from 2.25% in 1966 to 0.95% in 2018, while the death rate among 90-year-olds fell from 4.75% in 1965 to 0. 96% in 2017.

In addition, the growing demand for healthcare automation and high throughput procedures in diagnostic laboratories and research centers to ensure customer and patient satisfaction with error-free results or misinterpretation are other factors that lead to the growth of the APAC radioimmunoassay market over the forecast period.

However, the presence of an alternative method to immunoassay for detecting biomolecules poses a challenge for the growth of the APAC radioimmunoassay market. Moreover, the high cost of the equipment required for the procedures and the hazardous, radioactive material is estimated to hamper the market's growth.

This research report on the Asia Pacific Radioimmunoassay Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Reagents and Kits
  • Analyzers

By End User: 

  • Hospitals
  • Pharmaceutical Industry and CRO
  • Clinical Diagnostic Laboratories

By Application: 

  • Research
  • Clinical Diagnostics

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia-Pacific is projected to experience a healthy growth rate during the forecast period, owing to the large population vulnerable to various chronic diseases and increasing healthcare facilities.

China led the APAC market in 2020 and is forecasted to continue the APAC market throughout the forecast period due to the increasing adoption of technologically advanced devices, public awareness, high infection rates, better medical facilities, and increasing adoption of innovative products. In addition, government support and understanding are also increasing the growth of the Chinese market.

During the forecast period, the Japanese market is also estimated to grow at a promising CAGR. Furthermore, the market in this region is anticipated to witness significant growth during the forecast period, owing to the increasing prevalence of various infectious diseases and cancer, along with substantial investments in healthcare for research and development.

KEY MARKET PLAYERS:

Companies playing a notable role in the Asia Pacific RIA market profiled in this report are DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG, Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia Pacific Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  2. Asia Pacific Reagents and Kits Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia Pacific Analyzers Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia Pacific Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  5. Asia Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia Pacific Pharmaceutical Industry and CRO Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia Pacific Academics Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia Pacific Clinical Diagnostic Laboratories Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia Pacific Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  10. Asia Pacific Research Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia Pacific Clinical Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  12. Japan Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  13. Japan Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  14. Japan Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  15. China Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  16. China Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  17. China Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  18. India Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  19. India Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  20. India Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  21. Australia Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  22. Australia Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  23. Australia Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)
  24. South Korea Radioimmunoassay Market, By Type, From 2022 - 2027 (USD Million)
  25. South Korea Radioimmunoassay Market, By End User, From 2022 - 2027 (USD Million)
  26. South Korea Radioimmunoassay Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample